Research Sol. (RSSS) Q1 2027 Earnings Call Transcript

Source Motley_fool
Logo of jester cap with thought bubble.

Image source: The Motley Fool.

DATE

Tuesday, Nov. 17, 2026

CALL PARTICIPANTS

  • Investor Relations - John Beisler
  • Chairman and Chief Executive Officer - Roy W. Olivier
  • Chief Financial Officer - Dave Kutil
  • Chief Strategy Officer - Josh Nicholson

TAKEAWAYS

  • Total Revenue -- $11.9 million, representing a 3.3% decline reflecting lower transaction volume that offset top-line growth in platform subscriptions.
  • B2B ARR -- $16.5 million, growing 11.5% year over year driven by new logo generation and customer upsells.
  • AI-Related ARR -- $1.1 million, increasing 38% sequentially from the fourth quarter of fiscal 2026.
  • Total ARR -- $22.5 million, up 5.7% from $21.3 million in the prior-year period.
  • Platform Revenue -- $5.3 million, up 3.7% and now accounting for 44.6% of total revenue.
  • Transaction Revenue -- $6.6 million, down 8.2% due to lower paid order volume.
  • Consolidated Gross Margin -- 53.6%, a 300 basis point improvement due to the revenue mix shifting toward higher-margin platform business.
  • Platform Gross Margin -- 87.0%, compared to 88.1% in the prior year reflecting slightly higher hosting and technology costs.
  • Transaction Gross Margin -- 26.7%, a 280 basis point increase driven by improved margins on copyright content and pricing adjustments.
  • Net Income -- $765,000, or $0.02 per diluted share, compared to $749,000 in the first quarter of fiscal 2026.
  • Adjusted EBITDA -- $1.0 million, down from $1.5 million primarily due to higher general and administrative expenses and technology investments.
  • Adjusted EBITDA (Excluding Onetime Items) -- $1.5 million, after adjusting for approximately $500,000 in severance and legal costs.
  • Cash and Cash Equivalents -- $12.6 million, following $1.2 million in Scite earn-out payments during the quarter.
  • Operating Cash Flow -- $1.2 million, compared to $1.1 million in the prior-year quarter.
  • Net Platform Deployments -- 22, bringing the total count to 1,298 at the end of the quarter.
  • Active Transaction Customers -- 1,360, up from 1,326, as growth in academic customers offset a decline in corporate customers.
  • Pipeline ARR -- Over $5 million, representing the highest pipeline value in the company's history.
  • Average Sales Price -- $12,681, compared to $12,454 at the end of the prior-year period.
  • Operating Expenses -- $5.5 million, up 3.7% due to higher legal, severance, and product development spending.
  • AI Usage Metric -- 33 million papers read by AI assistants, representing a doubling since September 2026.
  • Scite B2C ARR -- Approximately $6 million, reflecting a decline from $6.3 million at the start of the quarter.
  • Copilot Integration -- The launch of an MCP for Copilot, enabling researchers to interact with supported large language models to retrieve copyright-compliant documents through Article Galaxy.

Need a quote from a Motley Fool analyst? Email pr@fool.com

RISKS

  • Roy W. Olivier stated, "While churn is not where we want it to be, we did see a slight improvement during Q1," noting that customer turnover remains a challenge for the business.
  • Olivier warned that the transaction segment faces "single-digit year-over-year declines in document delivery," driven by customer churn and potential shifts in research cycles.
  • Dave Kutil warned that the full-year adjusted EBITDA may be lower than previously expected because of "the delay in the new booking there and then some nonrecurring spend as well."

SUMMARY

Research Solutions (NASDAQ:RSSS) reported a shift in its business model as platform subscription revenue grew to offset declines in its transaction-based document delivery segment. The company stated that expansion of artificial intelligence capabilities through integrations with ChatGPT, Claude, and Microsoft Copilot has driven a doubling of AI-mediated research paper access. Management indicated that the company maintained its balance sheet strength with no long-term debt while continuing to fund earn-out payments for its Scite acquisition. The company stated that the strategic focus remains on converting large enterprise opportunities in the pipeline and stabilizing churn in the B2B segment.

  • Management reported closing a $1 million ARR deal in November 2026, representing the largest Scite-related expansion in company history.
  • Josh Nicholson stated, "49 business customers now have AI access written into their contracts, up from 42 last quarter."
  • The company launched a new version of the Scite Assistant that integrates search across literature, clinical trials, patents, and internal data sets.
  • Josh Nicholson noted that publishers are shifting their focus toward getting paid for content accessed by AI, with some now interested in selling metered reads to their material.
  • The company has completed six of the eight scheduled quarterly earn-out payments for the Scite acquisition as of Nov. 2, 2026.
  • Dave Kutil stated that the company expects to "turn the dial up a little bit on the advertising spend" by $100,000 to $200,000 in coming quarters.
  • Management stated that the recently closed $1 million ARR deal was the result of a year-long sales process involving multiple stakeholders and an in-depth review of AI and security protocols.

INDUSTRY GLOSSARY

  • ARR: Annual recurring revenue, a metric used to value contracted subscription revenue normalized to a one-year period.
  • Scite: A subsidiary platform that uses AI to provide citation context and verify the reliability of research papers.
  • Article Galaxy: A platform providing discovery and access to scientific literature while managing copyright compliance.
  • Gainsight: A software tool used by the company to manage customer success and reduce user churn.
  • STM: Scientific, Technical, and Medical, referring to the professional publishing market the company serves.
  • COUNTER: An industry standard for reporting content usage metrics to help publishers and libraries assess the value of subscriptions.

Full Conference Call Transcript

Operator: Good morning, everyone, and thank you for participating in today's conference call to discuss Research Solutions' Financial and Operating Results for its Fiscal 2027 First Quarter Ended September 30, 2026. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. John Beisler, Investor Relations. Please go ahead.

John Beisler: Thank you, Leslie, and good morning, everyone. Welcome to the Research Solutions first quarter fiscal year 2027 earnings call. With me today are Roy W. Olivier, Chairman and Chief Executive Officer; Dave Kutil, Chief Financial Officer; and Josh Nicholson, Chief Strategy Officer. After the market closed yesterday afternoon, the company issued a press release announcing its results for the first quarter of fiscal 2027. The release is available on the company's website at researchsolutions.com. Before management begins their prepared remarks, I would like to remind you that some of the statements made today will be forward-looking and made under the Private Securities Litigation Reform Act of 1995.

Actual results may differ materially from those expressed or implied due to a variety of factors. We refer you to Research Solutions' recent filings with the SEC for a more detailed discussion of the risks that could impact the company's future operating results and financial condition. Also on today's call, management will reference certain non-GAAP financial measures, which we believe provide useful information for investors. A reconciliation of these measures to GAAP measures is included in the earnings press release issued yesterday afternoon. Finally, I would like to remind everyone that this call will be recorded and made available for replay via a link on the company's website. I would now like to turn the call over to Roy W.

Olivier. Roy?

Roy Olivier: Thank you, John. As we continue to develop our next-generation AI-based research tools, we watch a few key metrics to ensure we're on track to that objective. We believe that publisher participation and customer adoption are two of the critical metrics, and we saw nice progress in Q1, offset by weakness in our B2C and document delivery business. While churn is not where we want it to be, we did see a slight improvement during Q1. Our B2B AI-related sales were up 38% sequentially from Q4 FY '26. And as reported last week, we closed a $1 million ARR deal last week and continue to see a number of 5-figure, 6-figure and some 7-figure opportunities in our pipeline.

We do have a stronger pipeline than at any time in the past. It's currently well over $5 million in ARR. In my mind, these early indicators reinforce that we're on the right path. We did launch an MCP for Copilot, supporting both Scite and Article Galaxy functionality. A researcher can interact with any supported LLM and then we ask that -- and then ask that LLM to go get those documents. And Article Galaxy will go get them in a copyright-compliant way. We're continuing to see strong adoption and interest of the previously released Claude Enterprise and ChatGPT solutions. As noted in our release, we continue to see nice expansion in our gross margins even on lower revenue.

Our excluding -- I'm sorry, after excluding for onetime events, primarily severance and legal costs, adjusted EBITDA was about $1.5 million. Operating cash flow was $1.2 million, and we continue to have a strong balance sheet with $12.6 million in cash and no long-term debt. This puts us in a strong position to invest where we think we'll see the biggest increase in shareholder value. I'll hand the call over to Dave to walk through our fiscal first quarter financial results in more detail, and then I'll come back with some comments and an outlook for the year ahead. Dave?

Dave Kutil: Thank you, Roy, and good morning, everyone. I'll start with the first quarter results and then cover cash flow and the balance sheet. Total revenue for the first quarter of fiscal 2027 was $11.9 million compared to $12.3 million in the first quarter of fiscal 2026. This increased platform revenue was more than offset by a decrease in transaction revenue. Our platform subscription revenue increased 3.7% to $5.3 million compared to $5.1 million in the prior year quarter. The growth was driven by an increase in B2B platform ARR due to a mix of new logo generation and upsells and cross-sells into our existing customer base, partially offset by a decline in B2C ARR.

We added 22 net new platform deployments in the quarter, bringing total deployments to 1,298 at quarter end. We ended the quarter with $22.5 million in annual recurring revenue, up 5.7% year-over-year, which breaks down as approximately $16.5 million in B2B ARR and approximately $6 million in normalized ARR associated with Scite's B2C subscribers. B2B ARR grew $1.7 million or 11.5% versus the year-ago period. In the quarter, net B2B ARR increased approximately $257,000, while normalized B2C ARR declined approximately $299,000. B2B ARR included AI-related ARR of approximately $1.1 million, up 38% from the end of fiscal 2026. Please see yesterday afternoon's press release for how we define and use annual recurring revenue and other non-GAAP terms.

Transaction revenue for the first quarter was approximately $6.6 million compared to $7.2 million in the prior year quarter, a decline of approximately 8%, primarily reflecting lower paid order volume. Our total active customer count for the quarter was 1,360 compared to 1,326 in the same period a year ago, with growth in academic customers more than offsetting a decline in corporate customers. Consolidated gross margin for the first quarter was 53.6%, a 300 basis point improvement over the first quarter of fiscal 2026. The increase is due to the ongoing revenue mix shift towards our higher-margin platform business, which now represents 44.6% of our total revenue, along with higher transaction margins.

Gross profit dollars grew 2.5% to $6.4 million despite the lower revenue base. The platform business recorded gross margin of 87% compared to 88.1% in the prior year quarter, reflecting slightly higher hosting and technology costs. Gross margin in our transactions business was 26.7% compared to 23.8% in the prior year quarter, a 280 basis point improvement. The increase was primarily attributable to improved margins on our copyright content, reflecting favorable publisher mix and pricing. Total operating expenses in the quarter were $5.5 million compared to $5.3 million in the prior year quarter.

Higher general and administrative expenses, primarily severance and legal costs and higher technology and product development spending were partially offset by lower sales and marketing expense and a noncash recovery of stock-based compensation resulting from forfeitures. Other expense for the quarter was $56,000 compared to $191,000 in the prior year quarter, primarily reflecting lower cash accreted interest on the Scite earn-out liability. As a reminder, as of November 2, we have completed 6 of the 8 quarterly Scite earn-out payments. Net income for the quarter was $765,000 or $0.02 per diluted share compared to $749,000 or $0.02 per diluted share in the prior year quarter.

Adjusted EBITDA for the quarter was $1 million or an 8.6% margin compared to $1.5 million for the first quarter of last year. The decrease reflects higher general and administrative costs and increased technology investment, partially offset by higher gross profit and lower sales and marketing expenses. Turning to cash flow. Cash flow from operations for the first quarter of the fiscal year was approximately $1.2 million compared to approximately $1.1 million in the prior year quarter, helped by the timing of vendor payments. Turning to our balance sheet. Cash and cash equivalents as of September 30, 2026, were $12.6 million, essentially unchanged from June 30, 2026, even after funding $1.2 million of cash Scite earn-out payments during the quarter.

There were no outstanding borrowings under our $500,000 revolving line of credit, and we have no long-term debt. With a solid cash position and no debt, our balance sheet gives us the flexibility to complete the remaining Scite earn-out payments in fiscal 2027, while at the same time, continuing to invest in the business. I'll now turn the call over to Josh. Josh?

Josh Nicholson: Thanks, Dave. Good morning, everyone. Today, I want to cover four things this quarter: How fast AI usage is growing, how it's showing up in our customer contracts, and how researchers and their agents are starting to buy content from us through their AI assistance and then the product work behind all of it. First, AI usage keeps growing fast. Since February, we've counted every time an AI assistant like Claude, ChatGPT or Copilot reads a research paper through us. At our last call in September, that was 16 million papers. Today, it's more than 33 million. It doubled in about two months. And as Roy mentioned, we're now available inside ChatGPT and Microsoft Copilot as well as Claude.

So researchers can reach our tools from whichever assistant their company uses. Second, AI is showing up in our business customers' contracts. Dave gave you the AI-related ARR figure. Behind it, 49 business customers now have AI access written into their contracts, up from 42 last quarter. Most are existing customers adding AI access when they renew or expand. And when they do, the contract typically gets meaningfully bigger. This quarter, we also closed the largest Scite deal in our history, and expansion of an existing Article Galaxy contract. That is the thesis we had on day 1 bringing Scite into Research Solutions. And a big thank you to our sales team for the work to get it done.

Third, researchers are starting to buy through their AI assistant. There's been a lot of talk this earnings season about AI agents making purchases. A few weeks ago, Uber said AI agents booked about 500 orders, 500 food orders and 4 rides over Halloween week, out of more than 300 million trips in orders. DoorDash said agents had placed several hundred orders in total. The consumer world is still waiting for agent-driven buying to take off. In our world, researchers are already buying this way.

In September, a researcher at a corporate customer can ask their AI assistant to get a paper, see the price, they buy it and then the order is placed on their company's account and delivered to the user with the copyright cleared. In October, researchers at more than 15 corporate customers, including several Fortune 500 enterprises, completed hundreds of articles and rights orders through their AI assistants and agents, up from a few dozen a month over the summer. It's still a small share of our total orders, but it's growing fast, and it's real business purchasing on invoice through existing accounts. We think research is one of the first places AI-assisted buying works for a simple reason.

About half of these assistants want to read is behind a paywall. When the assistant hits that wall, it needs a compliant way to get the paper and [indiscernible]. We have the publisher agreements, the pricing and the rights built up over 20 years. Fourth, a new Scite Assistant and what else we shipped. The biggest launch on Scite side is a completely new version of our AI research assistant. It brings everything we've built for AI assistants like Claude and ChatGPT into our own product with additional research-focused functionality layered on top.

A researcher can now search the literature and read full papers, but also clinical trials, drug safety data, patents and grants plus the open web and gray literature and upload their own files and work with them. Every answer is grounded in real cited sources, and it checks whether those citations are real and whether papers have been retracted. It became the default for individual users in October and is rolling out to all our institutional customers now. We also gave enterprise administrators a dashboard to see and manage how their organization uses AI.

On the Article Galaxy side, we opened AI access to all Article Galaxy customers, built ordering into AI assistant, as I described, made it simpler to buy the rights to use an article with AI and overhauled our reference manager. We also brought Scite inside Article Galaxy so open access papers come in automatically. On the publisher side, our AI reads reporting now shows publishers which of their journals AI assistants are reaching for and how often they've turned away at a paywall. That has changed our conversations with them. A year ago, publishers asked whether to let AI near their content. Now they ask how to get paid when it is.

We're talking with many of the publishers that we worked with for 20 years about what comes next and are excited about the progress on that front. To sum up, AI usage doubled since the last call, more business customers are building it into their contracts. Researchers are already buying articles through their AI assistants, and publishers want to work with us on it. AI isn't going to ground us. It's coming through us. Over to you, Roy.

Roy Olivier: Thanks, Josh and Dave. Thanks, everyone, for joining us. Really to close just three points. First, as Josh said, AI is coming through us, not around us. AI reads of research papers have doubled to more than 33 million since our last call. 49 million business customers now have AI access in their contracts and our pipeline -- I'm sorry, 49 business customers have AI access to their contracts. And our pipeline is over $5 million in ARR, stronger than at any point in our history. Second, it's showing up in the numbers. B2B ARR grew 11.5% to $16.5 million.

Total ARR reached $22.5 million and gross profit grew 2.5% or 300 basis points to 53.6% as platform grew to 45% of revenue. Third, we're doing this from a position of strength, $1.2 million of operating cash flow, $1.2 million paid toward the Scite earn-out and still $12.6 million in cash at quarter end with no long-term debt. We look forward to updating you further in February. With that, I'd like to turn it over to the operator for Q&A. Operator?

Operator: [Operator Instructions] And we will take our first question from Jacob Stephan with Lake Street Capital Markets.

Jacob Stephan: Maybe just first for me on the B2B side of things. I guess if you could kind of help us think through what gross bookings were in the quarter versus kind of churn dollars? And any additional comments that you have on churn and what you, kind of, see as we look forward here would be helpful on the B2B side.

Roy Olivier: Sure. Dave, do you want to take that?

Dave Kutil: Yes, sure. So we had about $500,000 in new bookings and look at our run rate the last two quarters, it's been a little choppy. The third quarter reported last year was about $1.3 million for the year-end quarter. So like I said, the choppiness kind of continues. But with the deal that we announced last week, that will be in this coming quarter. So we expect that to be strong.

From a churn perspective, we're pretty much up now on a nice run rate, not exactly where we'd like it to be, but compared to about a year ago when we, kind of, did all hands on deck churn analysis, put in Gainsight, we've come down about 30% from that. And so I look at the last three quarters, the trend has been pretty consistent of about $300,000 of churn. Again, not where we want to be, but some very significant improvement from when we decided to put in Gainsight and take all those strategic actions.

Jacob Stephan: Got it. And maybe just on the large deal that you guys announced. Could you maybe talk about just what the term is there, and how that [ bears ] comparison to maybe some of the smaller Scite deals that you have?

Roy Olivier: It's a 1-year deal, but it has a significant upside as we move into year 2 and 3. And it's the same terms as a normal agreement. I mean it's -- I believe, correct me if I'm wrong, Dave, platform upfront.

Dave Kutil: Correct.

Jacob Stephan: Okay. Got it. And then I just wanted to ask on the transaction side of things. Your active customers continue to grow. Revenue obviously is continued to be a little soft. But I guess that implies that orders per customer are falling. Is that more Agentic AI kind of substituting for the document buys or any budgets? And maybe what do you see in terms of the results stabilizing in the transaction segment?

Roy Olivier: Yes. We continue to see kind of single-digit year-over-year declines in document delivery. Most of that is really driven by customer churn, a couple of customers that we churned out that are still, kind of, a headwind to us in year-over-year growth. But we are seeing some other weakness, which we're not 100% sure, why. It could be Agentic AI. It could be just a phase in the research cycle. We can see it. But when we talk to customers about it, it's about why is yours in particular down? We don't really get super specific answers about why they're down because they just have research cycles and sometimes they're up and sometimes they're down.

But Josh, you may have some additional color on that.

Josh Nicholson: Yes. I don't have too much to kind of add to what Roy said. I think we're seeing better usage of the product. There's more search, there's more engagement. There's more access through tokens and subscriptions. And I think, again, there's more purchases now happening through this new mechanism of the agents than ever before. And so I still think a lot of this is somewhat of a hangover of losing one very large massive account. Roy and I go back a little bit between each other, is there a zero-click phenomenon? Is it not? And so that's certainly a possibility. There are less clicks throughout the web and more generally. And so it certainly could be.

But I do think there's the potential for the Agentic kind of consumption to increase and to be a meaningful line for DocDel, but still quite early days there.

Operator: We will take our next question from Derek Greenberg with Maxim Group.

Derek Greenberg: I wanted to first ask just about some of the outlook you provided on the last call, if there's been any material change or if you kind of see it as still your expectations for the year. It was for continued growth in corporate and academic B2B. B2C roughly flat year-over-year. Transactions down low single digits, which I think you just, kind of, mentioned and then improved adjusted EBITDA and cash flows.

Roy Olivier: Dave, any updates on that?

Dave Kutil: Yes. So from a B2B perspective, the timing of the large deal from when we last talked at year-end pushed out a little bit. So that will have an impact on top line sales, obviously, not ARR, but top line sales and that will flow through to EBITDA. That's -- it's not a huge amount. And remember, going forward, we're looking to build on that. And the MCP-related ARR that we talked about will continue to grow. But the B2C number that we said was flat. We expected the quarter to kind of play out like it did, and it was right on our budgeted number. We do see an uptick there to start this second quarter. It's persisting.

We're right in the middle of the quarter. So there perhaps may be a little bit of upside there, but we like to conservatively look at that because we know it's very cyclical and the winter break can sometimes disrupt that momentum. But we're optimistic with what we're seeing there. On the EBITDA side and the expense side, nothing really has changed from a cost structure standpoint. And what we're really happy with is the flow-through that we're seeing on the gross profit line. That has really been a strong portion that we've talked about quarter after quarter, but you can really see with our gross margins right now in 53-plus percent, that's also flowing through the bottom line.

So given that there's been a few items here from a cost standpoint that are more nonrecurring in nature and not part of our cost base going forward. We're very optimistic for the future. But the -- this quarter, obviously, was impacted by the delay in the new booking there and then some nonrecurring spend as well. So the full year, probably from an EBITDA perspective is going to be a little lower than the last time we talked. But from a run rate standpoint, EBITDA will continue to increase and probably even above what we talked about in the last conference call.

Derek Greenberg: Yes. That's really helpful. And then just on your sales force, I was wondering how you're feeling about the changes you've made over the past year or so? And maybe if you could talk about the performance of the different teams, new logos versus upsell, renewal, and any other color you want to provide?

Roy Olivier: Yes. I mean we continue to be -- we continue to see very strong activity pipeline and results in the corporate team. They're doing an amazing job. Academic team is doing a nice job. They've got a new leader. We've had some new headcount in that group. So they've had a little bit slower start than the corporate team. The renewal upsell team continues to do, I would describe it as a pretty good job on the upsell side, but we're -- it's still being offset too much by churn. So I'm happy to see we're seeing some slight improvement in churn based on the investments we made 6, 9 months ago in Gainsight.

And as I explained in the last call, we reorganized that group, added some additional people in that group to reduce the number of accounts per rep, which we think will pay off with better coverage and better customer communication in the coming quarters. So as we continue to see improvement in the churn side, we'll continue to see net ARR growth grow pretty significantly because, as I said, they do a nice job with upsells, just churn continues to be, in my opinion, our biggest pain point.

Derek Greenberg: Okay. That makes sense. Last one for me, just on sales cycles. I was wondering if you're seeing any material change from maybe where you've been historically, just given larger deal sizes or adding in the AI component?

Roy Olivier: I'm sorry, what was the first part of the question? In what cycle?

Derek Greenberg: Sales cycles.

Roy Olivier: Oh. Yes. Our -- we continue to have a pretty quick sales cycle. I mean it's typically 2, 3 months. A significant percentage of what we closed in the quarter was actually a deal generated during that quarter. However, these larger deals are taking longer. So the $1 million deal we did a press release on that had been a heads down, a lot of people working on a deal for a year. So it comes down to deal size in a lot of cases. We still do a lot of smaller deals, and those are typically pretty quick sales cycles.

But as we get into -- I mentioned, or I was going to mention, I think we did a $70,000 deal day before yesterday, did $100,000 deal, I think, last month. And then the $1 million deal, those take a little bit longer. Those were typically working 5, 6, 7 months to get them through all of the various approval levels, AI review, software tech, IT reviews. So smaller deals continue to be in that 2- to 3-month range, larger deals stretch it out a bit. But ASP goes up, which was nice.

Operator: We will take our next question from Richard Baldry with ROTH Capital.

Richard Baldry: You look specifically at the large deal. You talk about sort of how many peers are similarly scaled customers in terms of their own activities you'd have in your user base, sort of, trying to figure about how replicable that is over the long term and whether that was a large existing client that is steadily expanding, or there is a material step-up maybe due to something like the increased AI functionality?

Roy Olivier: We do have a -- we don't think that's a unique deal. We have other deals in the pipeline that are large, either in the 6 figures or even in the 7 figures that are similar. And they're driven by -- as these large corporations are trying to solve this problem, how do I connect these various silos? I've got a bunch of subscriptions for content. I've got a bunch of content I own. I've got Article Galaxy maybe already installed or something like Article Galaxy installed. And how can I streamline this research process and take steps out of it?

And one of the other deals we're working on, which is a pharma company about the size of the $1 million deal, that's also a 7-figure deal, and we're reducing the research kind of steps by 11 steps. And so when you spread that across thousands of researchers, it does speed up research and improves the quality of the output. And we're pricing the product to the value that we're delivering. So my point is, it's not a unique deal. The customer that signed a $1 million deal, they've been a long-time customer on the Article Galaxy side, but I think the revenue has probably been flattish for 5 years or more.

This is a material step up because we can materially impact the number of steps and the amount of time it takes them to do a research project. And that's kind of what we've been trying to build with being part of the infrastructure as opposed to being a plug-in here or there. But Josh, if you have any additional comments, go ahead.

Josh Nicholson: Yes. No, I think it's very replicable. I think there's another kind of interesting aspect in this in that like it's not just that there's AI functionality, it's also who we're talking to in the organizations. So AI budgets, both across corporate and academic, I would say, are growing, whereas historically, library budgets and content budgets are kind of flat or decreasing. And so involving new people into the conversation where these numbers are more of the norm, certainly makes it easier to close that deal. But I do think there are a whole host of AG customers that are decent size, have kind of been around, and I think there's a big opportunity to expand them.

And I think they're used to these, right? This is a big deal for us, but it's probably a normal sized license for a lot of these groups. And so I think, again, this kind of gets back to the thesis from day 1 is like, hey, we have an innovative tool. We have a great customer base. Let's go into that customer base and expand. And I think that's a mix of the AI, mix of the product, but really also a big testament to the sales team believing and knowing that, hey, this is not a one-off or an exceptional deal.

This is something that we can do over and over if we take our time, follow the process. And to Roy's point, involve a lot of different people, right? These deals do take a little bit longer. Product is heavily involved. There's more in-person visits, but all those things play out and are well worth it. And so I'm certainly excited about kind of some of the other deals that we're engaged in on the pipeline as well because I think, again, we don't want this just to be a onetime PR. We want this to be kind of the new norm going forward. And I think it certainly does reflect the value that we're bringing to these groups.

Richard Baldry: Okay. If I look at the transactions, gross margins, if I look at last year, it sort of started in the 24% zone, ended at 26%. Now you're just under 27%. Can you talk about the underlying trends that's improving that, how sustainable or extensible that could be?

Dave Kutil: Yes, I can take that one. We really feel like some of the actions we talked about two quarters ago are bearing fruit from -- not only -- again, we talk a lot about the platform transactions to platform transition, and that's still under probably the biggest driving factor. But we also looked at transactions pricing as well. So we're seeing some of that impact. We're maintaining, like we've said we would, maintaining our cost structure when it comes to cloud storage and AI costs as well. So we're managing those very well. And I think some of the savings projects, again, we referenced three quarters ago, are starting to bear fruit.

So it's really a confluence of all those events and strategies that make that margin, we think, pretty durable going forward.

Richard Baldry: Last for me. Look at, sort of, the movements within the OpEx lines. R&D was up a bit. Some onetime things, I think, impacted G&A and sales and marketing was down. How much do you think the 1Q sort of run rates reflect what we see going forward? Or can we get back to more like the stance we saw in the fourth quarter?

Dave Kutil: I think there will be a little bit into the second quarter. But like I said earlier, it's not going to be part of our run rate cost structure in the long term, certainly. So -- and some of the things I didn't comment on, on the research and development technology side that we're doing for security purposes, IT security projects that have kind of a 6-month life cycle here. We'll get those in place and then those kind of onetime project costs will go away. And we think then that supports everything that Josh and Roy were talking about these larger deals.

They do take a lot more time, but they also bolster some of the IT security that we have. And in concert with those actions, we'll feel like we're in great shape. And then the last thing I'll say, sales and marketing, we probably will ratchet that up a bit. I've talked in prior calls about the spend level being able to change that on a weekly basis. And because we're coming out of that, kind of, summer lull that we expected, and we're seeing some returns early in the middle part of this quarter, we probably will turn the dial up a little bit on the advertising spend.

So that's the one area where I'd say, we're probably a little lower actually in the first quarter of the fiscal year. And then going forward, we'll probably turn that up to the tune of another $100,000 or $200,000. But overall, the net run rate should be lower after we get through these projects and kind of onetime items.

Richard Baldry: Congrats on biggest deal.

Dave Kutil: Thanks.

Operator: [Operator Instructions] We will take our next question from Avi Fisher with Long Cast Advisers.

Unknown Analyst: What would you say -- it sounds like you have more large deals in the hopper. I just wondered if to gauge the probability or possibility of another $1 million-sized deal in the next 12 months or so.

Roy Olivier: I don't know how to guess that. I would say it's probable. I can't say whether it's 60% or 90%. It -- we have some deals that are well down that path with the longer sales path I described. And one in particular looks very good. But my experience doing elephant-type deals is never done until it's done, and there's 100 ways it can go sideways. So I wouldn't commit to it, but I think there's a good probability we'll close something. When you say end of the year, I assume you're talking fiscal year, not calendar.

Unknown Analyst: Yes, of course. And then how -- can you talk a little bit about how this product -- does it help your customers save money on token spend or just cut out steps in the process?

Roy Olivier: Yes, Josh, you can touch the token spend, but the steps in the process is big there because if you got 3,000 to 4,000 researchers, all of whom are high-income people, reducing steps is a big financial impact on your cost structure or your efficiency of the researchers. But Josh, do you want to touch on the token part of it?

Josh Nicholson: Yes. It's not really touching on kind of the token spend. If anything, in many of these kind of instances, they're using their tokens and not our tokens to do this. I think it's really the fact that they have a handful of different tools, their researchers, again, which can be in the hundreds or thousands, have to jump between these different tools and then they have to do this process, often medical writing, thousands of times a year. And so those steps that Roy mentioned as 11, like if you really break it down to all the steps, it's probably way more than that.

And so it's very clunky that they have, but they have to do certain things in certain ways. And so really, if you use Article Galaxy and Scite together, it's kind of a great one-two punch with AI to do things that still follow the regulatory steps that are necessary, but can help those humans cut down time and in some cases, cut down even the human work. And so I think it's really more about accelerating the time that the humans have to do and streamlining those workflows in, again, a copyright-compliant way.

If you need to check the reuse rights for hundreds of different articles and you have to do those one at a time, that's a huge pain, a lot of time. And if you can do that all automatically or even just at a glance, that alone is a big step in efficiency. And so we see that across a variety of different steps. And again, these calls are pretty fun to be in because you're untangling these big complex webs and providing a really nice solution to these groups.

Unknown Analyst: Yes, and meeting the customer where they are. I guess given your ability to grow organically and then to innovate organically and to generate cash flow organically, how come you're not aggressively buying back shares?

Roy Olivier: Well, we've talked about that before. I think everybody in the Board is in violent agreement that certainly where the share price is now, that's arguably the best use of cash. And as soon as we can announce something on that, that's more definitive, you'll see it. So it's not something we're doing today, but we agree that's a very, very good use of cash.

Operator: We will take our next question from George Melas with MKH Management.

George Melas: Can you guys talk a little bit about publisher participation? And I think, Josh, you talked -- in your prepared remarks, you talked about how your relationship with publishers is getting sort of deeper as you can show them more clearly which paper is read, which paper maybe people want to have access to but can't because of paywall. And how is that changing the conversation with some of your publishers?

Josh Nicholson: Yes. So across both products, we really want to be more strategic with publishers. And so we sit on a lot of very valuable data. What is being bought, what is being rented, what is being denied in AI, what is being used in AI. There is a new standard called COUNTER that is used to determine kind of the ROI or the value of subscriptions. And historically, that has been how do humans read content, right? How is it downloaded, how is it viewed, et cetera. COUNTER, as of the middle of October, put out new reports looking at Agentic usage. And so we are pretty uniquely able to, kind of, show that demand.

We have a public page that shows this broken down by publisher, broken down by journals, allows journals or publishers or societies to get these metrics and then to talk to us. And so that's a very active area of focus for us, where we are talking to publishers regularly, going to more events, and then I would say, evolving our current agreements that we have with them. These agreements with publishers can help publishers basically defend their subscription value in an AI world because we're giving them the metrics.

They can grow their subscription value again because we're giving them the metrics or -- and I think this is kind of the interesting area for some growth for both us and them, they can sell metered reads to their content into AI. And so there's a host of a few different start-ups also working in this area. There are some hosting agencies like Silverchair and Atypon also working in this area. But I think our big differentiators are our corporate customer base, which is by far the largest across anyone providing any sort of similar functionality and the fact that we already have these established relationships of sending royalties to publishers.

And so it's really nice narrative and data that we can show to publishers and say, "Hey, we want to work with you strategically to help bring your content into AI." And I really do think how content is consumed is transformationally, kind of, changing. If you look at print to web to AI, I think on average, people are reading maybe 20 articles a month. And now if you look at it an AI, the AI is consuming 300 to 600 articles per month. And so it's just a dramatic increase in kind of the consumption because AI can read an article instantly versus a human spending hours.

And so that is a big part of our strategy, is getting these publishers on board, exposing more of their content with them and then providing them strategic value through data and revenue so that they deeply engage with us. And so yes, a lot more kind of on the pipeline. We put out one press release on MDPI, and hopefully, there'll be some more coming soon, highlighting the traction we have there.

George Melas: Great. Okay. Lot to think about there. And maybe on the large transaction that you guys closed just a few weeks ago, how much is your content and access to publishers really important in that transaction? And how much is it really providing sort of the infrastructure to streamline their processes?

Josh Nicholson: Yes. So on that one, I think it's more kind of the latter. I think it's really the infrastructure there. Obviously, having good full text search across all these publisher relationships matter a ton. But if we had lost 1 or 2 publishers there, I don't think it would have changed the deal at all. And so I think we talk a lot about strategy, and we're giving you these kind of complex metered reads and all these different things. In this case, I think it's pretty simple, right? There are large customers out there that have simple challenges or maybe not simple challenges, large challenges.

And if we go in and leverage our long-standing relationship with them, we can show them, "Hey, here's how you can solve that." And that is a mixture of AI. It's a mixture of our content relationships on both products. And then I think also a testament to the sales team, right? We have some people that can really go and across and do these enterprise deals versus kind of tracking down at a smaller 6-figure deals, right? It takes some patience. It's a multi-stakeholder on both sides, their product and ours and a lot of listening and again, kind of, going to where the user is.

And so that, to me, is exciting because, again, we have a lot of very large customers. And in some cases, they're not paying the largest amount, right? And so that is an opportunity that I think we see.

Operator: At this time, there are no further questions in the queue. I would now like to turn our meeting back to Mr. Roy Olivier.

Roy Olivier: Thanks, everyone, for joining us on our call today. We look forward to speaking to you in February to discuss our second quarter FY '27 results. Have a great day.

Operator: Thank you. This brings us to the end of today's meeting. We appreciate your time and participation. You may now disconnect.

Should you buy stock in Research Solutions right now?

Before you buy stock in Research Solutions, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Research Solutions wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $327,620!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $959,410!*

Now, it’s worth noting Stock Advisor’s total average return is 802% — a market-crushing outperformance compared to 205% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of November 17, 2026.

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. Parts of this article were created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Gold Price Today: Can XAU/USD Hold $3,870? | Mitrade AUGold rebounds near US$3,870 after hitting a one-year low. Explore XAU/USD support, Fed risks and what the outlook means for Australian traders.
Author  Mitrade Team
14 hours ago
Gold rebounds near US$3,870 after hitting a one-year low. Explore XAU/USD support, Fed risks and what the outlook means for Australian traders.
placeholder
Nvidia faces its biggest earnings test yet — why Silicon Valley billionaires want Jensen Huang backNvidia faces a critical earnings test as investors weigh its AI growth outlook and leadership uncertainty. Discover why Silicon Valley billionaires want Jensen Huang back, what it could mean for Nvidia shares and how the results may shape the broader AI trade.
Author  Mark Garro
20 hours ago
Nvidia faces a critical earnings test as investors weigh its AI growth outlook and leadership uncertainty. Discover why Silicon Valley billionaires want Jensen Huang back, what it could mean for Nvidia shares and how the results may shape the broader AI trade.
placeholder
Berkshire Hathaway's Only New Q3 Position Is a Company Few Investors RecognizeBerkshire Hathaway’s only new third-quarter position is a Bending Spoons stake worth $689 million on Sept. 30. The Italian company, listed on Nasdaq as BSP, owns AOL, Evernote, and Vimeo.Berkshire’s F
Author  Beincrypto
20 hours ago
Berkshire Hathaway’s only new third-quarter position is a Bending Spoons stake worth $689 million on Sept. 30. The Italian company, listed on Nasdaq as BSP, owns AOL, Evernote, and Vimeo.Berkshire’s F
placeholder
Stocks, Gold, and Asia Bleed $2.2 Trillion: Top 5 Factors That Triggered the CrashGlobal markets lost roughly $2.2 trillion on November 16 as US stocks, precious metals, and Asian equities sold off together. Technology and AI-linked names led the decline.However, the rout did not s
Author  Beincrypto
20 hours ago
Global markets lost roughly $2.2 trillion on November 16 as US stocks, precious metals, and Asian equities sold off together. Technology and AI-linked names led the decline.However, the rout did not s
placeholder
Tom Lee Sees No Cracks in the AI Trade Despite Nasdaq's 12% DropTom Lee, head of research at Fundstrat Global Advisors, says the artificial intelligence (AI) trade remains structurally intact. The tech-heavy Nasdaq Composite had fallen nearly 12% from its Oct. 6 r
Author  Beincrypto
20 hours ago
Tom Lee, head of research at Fundstrat Global Advisors, says the artificial intelligence (AI) trade remains structurally intact. The tech-heavy Nasdaq Composite had fallen nearly 12% from its Oct. 6 r
goTop
quote